MARKET

ICLR

ICLR

ICON PLC
NASDAQ
309.56
+9.48
+3.16%
Opening 12:53 04/26 EDT
OPEN
302.85
PREV CLOSE
300.08
HIGH
310.34
LOW
300.25
VOLUME
325.27K
TURNOVER
0
52 WEEK HIGH
344.77
52 WEEK LOW
181.92
MARKET CAP
25.60B
P/E (TTM)
37.56
1D
5D
1M
3M
1Y
5Y
Icon Is Maintained at Outperform by Baird
Dow Jones · 4h ago
Barclays Remains a Buy on Icon (ICLR)
TipRanks · 8h ago
Buy Rating Affirmed for Icon Based on Strong Financials and Growth Potential
TipRanks · 10h ago
ICON (ICLR) Q1 Earnings Surpass Estimates, Margins Expand
NASDAQ · 23h ago
Truist Financial Reaffirms Their Buy Rating on Icon (ICLR)
TipRanks · 1d ago
ICON PLC: Report of foreign issuer
Press release · 1d ago
ICLR Stock Earnings: Icon Beats EPS, Meets Revenue for Q1 2024
Icon reported results for the first quarter of 2024. Icon reported earnings per share of $3.47. The company reported revenue of $2.09 billion. Icon's revenue was above the analyst estimate for revenue of  $2.08 billion.
Investorplace · 1d ago
ICON adjusts 2024 revenue, EPS guidance ranges
Clinical research organization ICON Plc has adjusted its 2024 outlook ranges for revenue and adjusted EPS. Revenue for the year is now seen as $8.48B-$8.72B. In Q1 2024, ICON missed on the bottom line though revenue came in-line.
Seeking Alpha · 1d ago
More
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.